Correlation Between RenovoRx and NewAmsterdam Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both RenovoRx and NewAmsterdam Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and NewAmsterdam Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and NewAmsterdam Pharma, you can compare the effects of market volatilities on RenovoRx and NewAmsterdam Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of NewAmsterdam Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and NewAmsterdam Pharma.

Diversification Opportunities for RenovoRx and NewAmsterdam Pharma

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between RenovoRx and NewAmsterdam is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and NewAmsterdam Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewAmsterdam Pharma and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with NewAmsterdam Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewAmsterdam Pharma has no effect on the direction of RenovoRx i.e., RenovoRx and NewAmsterdam Pharma go up and down completely randomly.

Pair Corralation between RenovoRx and NewAmsterdam Pharma

Given the investment horizon of 90 days RenovoRx is expected to generate 52.57 times less return on investment than NewAmsterdam Pharma. But when comparing it to its historical volatility, RenovoRx is 1.29 times less risky than NewAmsterdam Pharma. It trades about 0.0 of its potential returns per unit of risk. NewAmsterdam Pharma is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  196.00  in NewAmsterdam Pharma on November 28, 2024 and sell it today you would earn a total of  604.00  from holding NewAmsterdam Pharma or generate 308.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

RenovoRx  vs.  NewAmsterdam Pharma

 Performance 
       Timeline  
RenovoRx 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days RenovoRx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
NewAmsterdam Pharma 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in NewAmsterdam Pharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, NewAmsterdam Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

RenovoRx and NewAmsterdam Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with RenovoRx and NewAmsterdam Pharma

The main advantage of trading using opposite RenovoRx and NewAmsterdam Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, NewAmsterdam Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewAmsterdam Pharma will offset losses from the drop in NewAmsterdam Pharma's long position.
The idea behind RenovoRx and NewAmsterdam Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio